Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

BACKGROUND: In this study we aimed to monitor the risk of breakthrough SARS-CoV-2 infection in patients with MS (pwMS) under different DMTs and to identify correlates of reduced protection. METHODS: This is a prospective Italian multicenter cohort study, long-term clinical follow-up of the CovaXiMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sormani, Maria Pia, Schiavetti, Irene, Inglese, Matilde, Carmisciano, Luca, Laroni, Alice, Lapucci, Caterina, Visconti, Valeria, Serrati, Carlo, Gandoglia, Ilaria, Tassinari, Tiziana, Perego, Germana, Brichetto, Giampaolo, Gazzola, Paola, Mannironi, Antonio, Stromillo, Maria Laura, Cordioli, Cinzia, Landi, Doriana, Clerico, Marinella, Signoriello, Elisabetta, Cocco, Eleonora, Frau, Jessica, Ferrò, Maria Teresa, Di Sapio, Alessia, Pasquali, Livia, Ulivelli, Monica, Marinelli, Fabiana, Pizzorno, Matteo, Callari, Graziella, Iodice, Rosa, Liberatore, Giuseppe, Caleri, Francesca, Repice, Anna Maria, Cordera, Susanna, Battaglia, Mario Alberto, Salvetti, Marco, Franciotta, Diego, Uccelli, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069178/
https://www.ncbi.nlm.nih.gov/pubmed/35526306
http://dx.doi.org/10.1016/j.ebiom.2022.104042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069178/
https://www.ncbi.nlm.nih.gov/pubmed/35526306
http://dx.doi.org/10.1016/j.ebiom.2022.104042

Ejemplares similares